This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): IDflu
Intanza is an intradermal microinjection season influenza vaccine using a pre-filled microinjection system. It is a split virion, non-adjuvanted, trivalent influenza vaccine.
Intanza utilizes BD (Becton, Dickinson and Company)'s novel intradermal injection solutions to administer Intanza. These solutions are based on BD's commercialized intradermal injection technology, BD Soluvia Microinjection System.
Additional information available to subscribers only: